HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Barbara Schmidt Selected Research

Caffeine (No Doz)

11/2015Prediction of Late Death or Disability at Age 5 Years Using a Count of 3 Neonatal Morbidities in Very Low Birth Weight Infants.
8/2015Predicting severe motor impairment in preterm children at age 5 years.
4/2015Social variables predict gains in cognitive scores across the preschool years in children with birth weights 500 to 1250 grams.
10/2014Long-term effects of caffeine therapy for apnea of prematurity on sleep at school age.
8/2014Reduction in developmental coordination disorder with neonatal caffeine therapy.
1/2012Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity.
10/2011Impact of delivery room resuscitation on outcomes up to 18 months in very low birth weight infants.
1/2011Economic evaluation of caffeine for apnea of prematurity.
3/2010Caffeine for Apnea of Prematurity trial: benefits may vary in subgroups.
1/2008Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Barbara Schmidt Research Topics

Disease

12Apnea
11/2015 - 01/2005
9Bronchopulmonary Dysplasia
12/2015 - 05/2002
9Infection
02/2015 - 09/2004
8Birth Weight (Birth Weights)
11/2015 - 05/2002
6Cerebral Palsy (Spastic Diplegia)
12/2015 - 11/2007
6Retinopathy of Prematurity (Retrolental Fibroplasia)
11/2015 - 04/2002
5Patent Ductus Arteriosus
01/2011 - 02/2006
3Brain Injuries (Brain Injury)
11/2015 - 03/2003
3Lung Injury
01/2013 - 01/2006
3Pulmonary Edema
01/2013 - 01/2006
3Hemorrhage
01/2013 - 12/2005
3Edema
07/2007 - 02/2005
2Wounds and Injuries (Trauma)
09/2013 - 09/2010
2Weight Gain
01/2013 - 05/2006
2Inflammation
01/2012 - 05/2006
2Weight Loss (Weight Reduction)
06/2006 - 08/2003
1Hypertrophic Cardiomyopathy (Asymmetric Septal Hypertrophy)
12/2015
1Melanoma (Melanoma, Malignant)
10/2015
1Bradycardia
08/2015
1Anoxia (Hypoxia)
08/2015
1Obstructive Sleep Apnea
10/2014
1Sleep Apnea Syndromes (Sleep Apnea)
10/2014
1Motor Skills Disorders (Motor Skills Disorder)
08/2014
1Cicatrix (Scar)
03/2014
1Sepsis (Septicemia)
03/2014
1Polydactyly (Polydactylism)
03/2014
1Immune Reconstitution Inflammatory Syndrome
01/2013
1Body Weight (Weight, Body)
01/2013
1Cross Infection (Nosocomial Infection)
01/2013
1Growth Disorders
09/2012
1Hypertrophy
09/2012
1Disease Progression
01/2012
1Hearing Loss (Hearing Impairment)
10/2011
1Meningoencephalitis
01/2011
1Herpes Zoster
01/2011
1Lung Diseases (Lung Disease)
01/2011
1Neurologic Manifestations (Neurological Manifestations)
01/2011
1Neuralgia (Stump Neuralgia)
01/2011
1Dermatitis
02/2010
1Eye Infections
02/2010
1Ventilator-Induced Lung Injury
07/2006
1Pneumonia (Pneumonitis)
01/2006
1Endotoxemia
01/2006
1Jaundice
09/2005
1Tonic Pupil
02/2005
1Rupture
12/2004

Drug/Important Bio-Agent (IBA)

13Caffeine (No Doz)FDA LinkGeneric
11/2015 - 01/2005
10OxygenIBA
12/2015 - 05/2002
7Indomethacin (Indometacin)FDA LinkGeneric
02/2008 - 05/2002
3ROPIBA
11/2015 - 03/2003
3InterferonsIBA
01/2013 - 09/2004
2Purinergic P1 Receptors (Adenosine Receptor)IBA
10/2014 - 09/2013
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2013 - 01/2012
2CD40 Ligand (CD40L)IBA
01/2013 - 01/2012
2Adrenal Cortex Hormones (Corticosteroids)IBA
07/2011 - 01/2008
2Interferon Type IIBA
02/2010 - 09/2008
2methylxanthineIBA
11/2007 - 01/2005
2CytokinesIBA
07/2007 - 01/2006
2tyrosyl- 1,2,3,4- tetrahydro- 3- isoquinolinecarbonyl- phenylalanyl- phenylalanine (TIPP)IBA
06/2006 - 05/2002
2Insulin (Novolin)FDA Link
05/2004 - 08/2003
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2015
1Carbon MonoxideIBA
10/2015
1Amyloid (Amyloid Fibrils)IBA
02/2015
1AntigensIBA
01/2015
1dicarboxydine (DCD)IBA
08/2014
1CosmeticsIBA
03/2014
1Transforming Growth Factor beta (TGF-beta)IBA
09/2013
1Messenger RNA (mRNA)IBA
09/2013
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
09/2013
1PeptidesIBA
01/2013
1Recombinant ProteinsIBA
01/2013
1First StepIBA
09/2012
1Prednisolone (Predate)FDA LinkGeneric
01/2012
1Interferon-alpha (Interferon Alfa)FDA Link
01/2012
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2012
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2012
1PlasminogenIBA
01/2012
1lipopolysaccharide-binding proteinIBA
01/2012
1enhanced green fluorescent proteinIBA
09/2010
1glucuronyl glucosamine glycan sulfate (Vessel)IBA
09/2010
1Erythromycin (Erycette)FDA LinkGeneric
02/2010
1CPG-oligonucleotideIBA
02/2010
1Gentamicins (Gentamicin)FDA LinkGeneric
02/2010
1Vitamin A (Retinol)FDA LinkGeneric
01/2008
1DobutamineFDA LinkGeneric
07/2007
1FoscarnetFDA LinkGeneric
02/2005

Therapy/Procedure

5Artificial Respiration (Mechanical Ventilation)
03/2014 - 01/2005
2Catheters
12/2015 - 01/2002
2Positive-Pressure Respiration (PEEP)
03/2010 - 05/2006
2Mechanical Ventilators (Ventilator)
02/2008 - 01/2006
2Drug Therapy (Chemotherapy)
01/2008 - 05/2006
1Immunomodulation
01/2012
1Resuscitation
10/2011
1Organ Transplantation
01/2011
1Transplantation (Transplant Recipients)
01/2011
1Kidney Transplantation
01/2011
1Amputation
09/2010
1Therapeutics
02/2010
1Liver Transplantation
09/2005
1Laparotomy
12/2004